Nephrotic syndrome (NS) is one of the common yet challenging childhood disease. Treating NS with immunosuppressants like corticosteroids is typically effective. However, there are significant evidences which displayed resistance patterns to the former drugs. Here in this case, a male patient came to the nephrology department with the history of steroid dependant nephrotic syndrome with complaint of its infrequent relapse. The condition was complicated since, the patient was on multiple steroids even after which there were recurrent episodes of syndrome. Considering the status, Mycophenolate mofetil was added as a supportive treatment for the management of the disease along with steroids, still the outcome was unremarkable. Hence, rituximab ...
International audienceSeveral case reports suggest that rituximab (RTX) could be effective in steroi...
Aim: We aimed to evaluate the efficacy of rituximab therapy in children with nephrotic syndromes and...
Background: Since the early 2000s rituximab (RTX) has been thought of as an alternative treatment fo...
Background: Nephrotic syndrome (NS) in children is a disease of glomerular filtration barrier failur...
BACKGROUND: Steroid-sensitive nephrotic syndrome is the most common form of nephrotic syndrome in ch...
Childhood nephrotic syndrome is a challenging and often persistent renal disorder, and its incidence...
Idiopathic nephrotic syndrome is the most common chronic glomerular disease in children. A total of ...
Background/aim: This study aimed to evaluate the efficacy of rituximab in children with difficult-to...
Background/aim: This study aimed to evaluate the efficacy of rituximab in children with difficult-to...
Steroid-dependent nephrotic syndrome (SDNS) carries a high risk of toxicity from steroids or steroid...
BACKGROUND: The anti-CD20 monoclonal antibody rituximab (RTX) has been proposed as a rescue therapy ...
Corticosteroid resistant and dependent nephrotic syndrome in children is a challenge and there are s...
OBJECTIVE: Most cases of idiopathic nephrotic syndrome in childhood are responsive to corticosteroid...
Recently, the role of B cells in the pathogenesis of nephritic syndrome is explained by some researc...
International audienceAlthough most patients with idiopathic nephrotic syndrome (NS) respond to ster...
International audienceSeveral case reports suggest that rituximab (RTX) could be effective in steroi...
Aim: We aimed to evaluate the efficacy of rituximab therapy in children with nephrotic syndromes and...
Background: Since the early 2000s rituximab (RTX) has been thought of as an alternative treatment fo...
Background: Nephrotic syndrome (NS) in children is a disease of glomerular filtration barrier failur...
BACKGROUND: Steroid-sensitive nephrotic syndrome is the most common form of nephrotic syndrome in ch...
Childhood nephrotic syndrome is a challenging and often persistent renal disorder, and its incidence...
Idiopathic nephrotic syndrome is the most common chronic glomerular disease in children. A total of ...
Background/aim: This study aimed to evaluate the efficacy of rituximab in children with difficult-to...
Background/aim: This study aimed to evaluate the efficacy of rituximab in children with difficult-to...
Steroid-dependent nephrotic syndrome (SDNS) carries a high risk of toxicity from steroids or steroid...
BACKGROUND: The anti-CD20 monoclonal antibody rituximab (RTX) has been proposed as a rescue therapy ...
Corticosteroid resistant and dependent nephrotic syndrome in children is a challenge and there are s...
OBJECTIVE: Most cases of idiopathic nephrotic syndrome in childhood are responsive to corticosteroid...
Recently, the role of B cells in the pathogenesis of nephritic syndrome is explained by some researc...
International audienceAlthough most patients with idiopathic nephrotic syndrome (NS) respond to ster...
International audienceSeveral case reports suggest that rituximab (RTX) could be effective in steroi...
Aim: We aimed to evaluate the efficacy of rituximab therapy in children with nephrotic syndromes and...
Background: Since the early 2000s rituximab (RTX) has been thought of as an alternative treatment fo...